Delivery Order SPE2DB22D3019-SPE2DB24FK3UU
Award Date
8/28/24
Potential Completion Date
8/29/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DB22D1017|SPE2DB24FG1SR, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of 4,565,218,487 units of Alfuzosin HCL ER 10 mg tablets in 120-count bottles. This is a Firm Fixed Price Delivery Order contract with a ceiling value of $1,560.68 and an ultimate completion date of July 23, 2024. The contract does not have a set-aside...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,325,624 units of the prescription medication Alfuzosin HCl ER 10 mg Tablet. The $2,421.58 firm fixed price contract has a period of performance through April 19, 2024 and is not set aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
This federal contract award, with ID SPE2DB24D1021|SPE2DB24FERQX, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,389.86, is for the delivery of Alfuzosin HCL ER 10 mg tablets. This is a firm fixed-price delivery order contract with a completion date of May 17, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,329.88, is a delivery order for the supply of Alfuzosin HCL ER 10 mg tablets. The contract has an ultimate completion date of March 26, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds...
This federal contract award, valued at $5,436.87, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Alfuzosin HCL ER 10 mg tablets, a pharmaceutical product, and has a performance period through May 15, 2025. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,522.35, is for the delivery of Alfuzosin HCL ER 10 mg tablets. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award, valued at $1,017.90, is for the delivery of Alfuzosin HCL ER 10 MG Tablets in 90-count packages. The contract has an ultimate completion date of December 19, 2024 and is a firm fixed-price delivery order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical is for the delivery of Alfuzosin Hydrochloride Extended-Release 10 mg Tablets in packages of 90. The contract has a firm fixed price of $4,206.45 and an ultimate completion date of September 25, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This contract is not a set-aside and is a delivery order under a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, valued at $5,603.19, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Alfuzosin HCL ER 10 mg tablets, a medication used to treat benign prostatic hyperplasia. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,018.77, is for the delivery of Alfuzosin HCL ER 10 mg tablets. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...